Ignite Creation Date:
2024-05-06 @ 11:16 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03473691
Status:
WITHDRAWN
Last Update Posted:
2018-06-01
First Post:
2018-02-14
Brief Title:
Pilot Study of Glembatumumab Vedotin Following Doxorubicin and Cytoxan as Neo-adjuvant Therapy in Gp-NMB-expressing High Risk Triple Negative Breast Cancer
Sponsor:
University of Virginia
Organization:
University of Virginia
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Triple Negative Breast Cancer |
Keywords: